Biotech News | By Tag

OncoBeta Introduces Rhenium-SCT for Non-Melanoma Skin Cancer at Theageneio Cancer Hospital of Thessaloniki

Medical, Health, Marketing, Biotech

New Patient Data Show REQORSA® Activating Cellular Repair Pathways as Roche Collaboration Advances Precision Lung Cancer Strategy for Genprex, Inc

Business, Health, Biotech, Stocks, Financial, Nasdaq

New TROP2 Research Breakthrough Strengthens REQORSA® Gene Therapy Story as Roche Collaboration Advances Precision Lung Cancer Treatment: Genprex, Inc

Business, Health, Biotech, Stocks, Financial, Nasdaq

FDA Approval; Major Milestone for Preservative-Free Ketamine Ahead of FDA Goal Date for Treatment of Suicidal Depression by NRx Pharmaceuticals, Inc

Business, Finance, Medical, Health, Marketing, Media, Healthcare, Biotech, Stocks, Stock Market, Financial, Nasdaq

Major FDA Victory; Preservative-Free Ketamine Approved Ahead of November 10 Goal Date as Commercial Launch Opportunity Comes Into Focus for NRx Pharma

Business, Finance, Medical, Health, Marketing, Media, Healthcare, Biotech, Stocks, Stock Market, Financial, Nasdaq

New Research Spotlight, Expanding TUSC2 Science & Strategic Development Milestones Put Gene Therapy Innovation into Focus for Genprex (NAS DAQ: GNPX)

Business, Health, Biotech, Stocks, Financial, Nasdaq

Expanding Into Medically Supervised Wellness With Major Apollo Wellness Centers Announcement; Sibannac, Inc. (Stock Symbol: SNNC)

Business, Medical, Health, Healthcare, Biotech, Stocks, Stock Market, Financial

Commercial Manufacturing Validation Completed as November 10 FDA Milestone Approaches; Critical FDA Milestone Close: NRx Pharmaceuticals NAS DAQ: NRXP

Business, Finance, Medical, Health, Marketing, Media, Healthcare, Biotech, Stocks, Stock Market, Financial, Nasdaq

Critical FDA Milestone much Closer as Preservative-Free Ketamine Review Advances: NRx Pharmaceuticals (N A S D A Q: NRXP)

Business, Finance, Medical, Health, Marketing, Media, Healthcare, Biotech, Stocks, Stock Market, Financial, Nasdaq

ClearSight Therapeutics Receives U.S. Patent Notice of Allowance

Consumer, Health, Biotech

Danish company biosuite introduces biotech procurement software to track outsourced R&D commitments

Software, Science, Biotech

$11.18 Million DARPA Award Ignites a Major New Catalyst as FDA, Robotic TMS and Commercialization Milestones Converge for NRx Pharmaceuticals, Inc

Business, Finance, Medical, Health, Marketing, Media, Healthcare, Biotech, Stocks, Stock Market, Financial, Nasdaq

Nutriband (N A S D A Q: NTRB): Fighting Back Against the Fentanyl Crisis With a New Approach to Safer Transdermal Medicines

Business, Medical, Health, Biotech, Stocks, Stock Market, Financial, Nasdaq

Most Utah Deaths Never Reach the Medical Examiner. Postmortem Pathology Offers Salt Lake City a Private Autopsy Option

Business, Family, Health, Technology, Biotech

Nutriband Inc. (N A S D A Q: NTRB) Breaks Into Uncharted Territory: 52-Week High Eclipsed as Shares Surge 22% —AVERSA™ Puts Investors on High Alert

Business, Medical, Health, Biotech, Stocks, Stock Market, Financial, Nasdaq

Thar Process Partners with French Leader ExtrateX to Bring Prep to Process-Scale SFC to Europe

Technology, Manufacturing, Biotech

Biophysical Therapeutics brings longevity science to skincare with its new IF1 brand

Health, Science, Biotech, Women

ClearSight Therapeutics Receives NIH SBIR Phase I Award for Conjunctivitis and EKC Research

Consumer, Health, Technology, Manufacturing, Biotech

Lunai Bioworks (N A S D A Q: LNAI) Takes Parkinson's Discovery to the Next Level With Exclusive Tanaist Agreement

Business, Health, Biotech, Research, Stocks, Artificial Intelligence, Stock Market, Financial, Nasdaq

Independent Autopsies Are Changing Civil Cases: Kansas City Forensic Explains Why Families Are Seeking Second Opinions

Medical, Health, Technology, Lifestyle, Biotech

Warrant Activity, AVERSA™ Progress and a Potentially Transformative Fall Take Center Stage: Nutriband Inc. (N A S D A Q: NTRB)

Business, Medical, Health, Biotech, Stocks, Stock Market, Financial, Nasdaq